Edwin Moses | How to build large biotech platforms | E13

We’re in Brussels with Edwin Moses, the former CEO of one of the most successful platform companies in Europe, Ablynx, now part of Sanofi. We talk about how he feels 5 years after the exit from Ablynx and his lessons. We also talk about the parallels between industrial biotech, AI bio and cell therapy, and how a chairman can help CEOs grow. 💎 ABOUT THE SPEAKEREdwin Moses is Chairman of Achilles Thx (cell therapy for solid tumors), Avantium (bioplastics) and LabGenius (AI biotech). He is the former CEO of one of the most successful platform companies in Europe, Ablynx, now part of Sanofi. I interviewed him back in 2018 when he sold the company. 📜 TRANSCRIPTRead the full transcript here: https://flot.bio/episode/edwin-moses-biotech-platforms/🔗 LINKS MENTIONEDSanofi to acquire Ablynx for €3.9 Billion - https://www.sanofi.com/en/media-room/press-releases/2018/2018-01-29-07-19-03-1313306Edwin Moses on stage in 2018 - https://www.youtube.com/watch?v=nWkd99rxVhc&t=802s&pp=ygUVZWR3aW4gbW9zZXMgbGFiaW90ZWNo 📖 SHORT BLOGS BASED ON THIS EPISODE:Baker Brothers' Biotech Investing Secrets: https://flot.bio/baker-brothers-investing-secrets/🫶 FOLLOW USNewsletter: http://eepurl.com/h_fnmHLinkedIn: https://www.linkedin.com/company/flot-bio/ X (Twitter): https://x.com/FlotBio 🎙️ ABOUT FLOT.BIOFlot.bio is a show to watch the best Europeans in biotech to help you grow. Hosted by Philip Hemme. 15k monthly views. Free. ⭐️ SPONSORSHIPReady to amplify your brand to influential leaders in biotech and biopharma? Contact [email protected] and unlock sponsorship opportunities in our podcasts! 🙏 LIKE/FOLLOW/REVIEWDid you enjoy the episode? Please hit the like and subscribe button. Also, please let me know your thoughts in the comments below. ⏰ TIMESTAMPS[00:00:00] Intro[00:01:52] After the Ablynx acquisition[00:14:49] Baker Brothers investor secrets[00:25:12] How to build a platform company[00:38:57] Getting onto the board of an industrial biotech[00:48:41] What makes an entrepreneur[00:51:36] How AI biotech can help R&D[01:04:22] The lowest market cap for Achilles[01:10:53] The draw of being the Chairman[01:23:35] Thanks for listening